Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-139084

Published: 2020

Journal Articles

RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples

Mara Rosenberg, BS, Cristina E. Tognon, PhD, Kevin M Watanabe-Smith, PhD, Uma Borate, MD

Blood (2018) 132 (Supplement 1): 1365.

https://doi.org/10.1182/blood-2018-99-120296

Published: 2018

Journal Articles

Distinct Mechanisms of Receptor Activation Are Associated with CSF3R Gain-of-Function Mutations

Haijiao Zhang, Julia E. Maxson, PhD, Kevin M Watanabe-Smith, PhD, Cody Coblentz, Jeffrey W. Tyner, PhD

Blood (2017) 130 (Supplement 1): 4985.

https://doi.org/10.1182/blood.V130.Suppl_1.4985.4985

Published: 2017

Journal Articles

A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes

Kevin M Watanabe-Smith, BS, Cristina E. Tognon, PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD, Anupriya Agarwal, PhD

Blood (2015) 126 (23): 3670.

https://doi.org/10.1182/blood.V126.23.3670.3670

Published: 2015

Journal Articles

Rh null Syndrome: Identification of a Novel Mutation in RHce Gene.

Marion E. Reid, PhD, Karina A. Rosa, Vivien I. Powell, Christine Lomas-Francis, Fernando F. Costa, MD, PhD, Servio T. Stinghen, Alexandra M. Watanabe, Edna K. Carboni, Joseani P. Baldon, Maria Marta F. Jucksch, MD, Lilian Castilho, PhD

Blood (2004) 104 (11): 2708.

https://doi.org/10.1182/blood.V104.11.2708.2708

Published: 2004

Journal Articles

Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Ph1-positive acute lymphoblastic leukemia with myeloid surface markers [letter] [see comments]

H Tsuchiya, N Adachi, N Asou, K Takatsuki, I Matsuda, F Kawano, T Murakami, S Mizutani, M Watanabe

Blood (1991) 77 (2): 411–413.

https://doi.org/10.1182/blood.V77.2.411a.411a

Published: 1991

NARROW

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples

Distinct Mechanisms of Receptor Activation Are Associated with CSF3R Gain-of-Function Mutations

A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes

Rh null Syndrome: Identification of a Novel Mutation in RHce Gene.

Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Ph1-positive acute lymphoblastic leukemia with myeloid surface markers [letter] [see comments]

Email alerts

ASH Publications

American Society of Hematology

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples

Distinct Mechanisms of Receptor Activation Are Associated with CSF3R Gain-of-Function Mutations

A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes

Rh null Syndrome: Identification of a Novel Mutation in RHce Gene.

Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in Ph1-positive acute lymphoblastic leukemia with myeloid surface markers [letter] [see comments]

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only